GleamWall
中文EN

MCK MCKESSON CORP

Wholesale-Drugs, Proprietaries & Druggists' Sundries · NYSE · SEC CIK 927653 · Fiscal year ends 03/31

Financial factors as of 2026-09-30 (2027Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY8.2%
TTM net income YoY16.5%
TTM EPS YoY21.1%
Revenue 3-yr CAGR12.9%
Net income 3-yr CAGR10.5%

Margins

Gross margin3.7%
Operating margin1.6%
Net margin1.1%
FCF margin1.7%
EBITDA margin1.7%

Returns

ROE—
ROA5.3%
ROIC (approx.)1,481.2%
Asset turnover4.75x

Leverage & solvency

Liabilities / assets101.1%
Debt / equity—
Current ratio0.90x
Interest coverage21.87x

Cash quality & payout

Operating cash flow / net income1.60x
Accruals ratio-3.2%
Payout ratio8.5%
Capex / revenue0.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2027Q22026-09-302027Q12026-06-302026Q4*2026-03-312026Q32025-12-312026Q22025-09-302026Q12025-06-302025Q4*2025-03-312025Q32024-12-31
Income statement
Revenue$110.96B$105.38B$96.30B$106.16B$103.15B$97.83B$90.82B$95.29B
Cost of revenue$107.00B$101.69B$92.25B$102.47B$99.61B$94.55B$87.18B$92.01B
Gross profit$3.96B$3.69B$4.04B$3.69B$3.54B$3.28B$3.64B$3.28B
SG&A expense$2.27B$2.26B$1.80B$2.03B$2.07B$2.20B$1.98B$2.03B
Operating income$1.60B$1.32B$2.15B$1.62B$1.41B$1.04B$1.59B$1.22B
Interest expense$105.00M$77.00M$61.00M$63.00M$74.00M$49.00M$45.00M$67.00M
Pretax income$1.56B$1.31B$2.12B$1.63B$1.40B$1.05B$1.51B$1.23B
Income tax$266.00M$276.00M$270.00M$380.00M$232.00M$220.00M$209.00M$298.00M
Net income$1.22B$614.00M$1.68B$1.19B$1.11B$784.00M$1.26B$879.00M
EBITDA$1.80B$1.51B$1.90B$1.81B$1.59B$1.19B$1.38B$1.38B
EPS (basic)10.475.17—9.638.956.28—6.98
EPS (diluted)10.445.15—9.598.926.25—6.95
Dividends declared per share0.940.820.820.820.820.710.710.71
Weighted avg. shares (diluted)116.70M119.20M—123.70M124.40M125.50M—126.60M
Balance sheet
Cash & equivalents$6.53B$5.16B$3.98B$2.96B$4.00B$2.42B$5.96B$1.13B
Receivables$30.81B$30.32B$27.98B$28.21B$28.29B$28.16B$25.64B$25.83B
Inventory$28.22B$26.26B$24.21B$27.07B$26.13B$25.07B$23.00B$23.84B
Current assets$66.69B$62.84B$57.21B$59.70B$59.89B$56.80B$55.40B$51.74B
PP&E, net$2.67B$2.68B$2.67B$2.63B$2.63B$2.57B$2.50B$2.40B
Goodwill$11.27B$11.28B$11.32B$11.32B$11.28B$11.37B$10.02B$10.00B
Intangibles$3.94B$4.01B$4.08B$4.18B$4.22B$4.27B$1.46B$1.51B
Total assets$92.32B$88.33B$82.32B$84.19B$84.16B$81.31B$75.14B$71.08B
Current liabilities$74.40B$70.36B$67.02B$68.13B$68.03B$64.33B$61.60B$58.56B
Short-term debt$794.00M$1.30B$1.27B$1.13B$1.75B$1.25B$1.19B$2.42B
Long-term debt$8.41B$8.43B$5.26B$5.42B$6.01B$6.53B$4.46B$4.42B
Total debt$9.21B$9.73B$6.53B$6.56B$7.76B$7.78B$5.65B$6.85B
Total liabilities$93.34B$89.63B$83.16B$84.29B$84.74B$82.17B$76.83B$73.78B
Shareholders' equity-$3.95B-$4.24B-$2.17B-$1.30B-$1.74B-$1.97B-$2.07B-$3.08B
Net debt$2.68B$4.57B$2.55B$3.60B$3.75B$5.36B-$302.00M$5.72B
Cash flow statement
Operating cash flow$3.07B-$220.00M$3.42B$1.23B$2.42B-$918.00M$7.75B-$2.38B
Capital expenditure$65.00M$112.00M$111.00M$108.00M$106.00M$111.00M$169.00M$126.00M
Free cash flow$3.00B-$332.00M$3.31B$1.12B$2.31B-$1.03B$7.58B-$2.51B
Investing cash flow-$130.00M-$214.00M$425.00M-$269.00M-$24.00M-$3.56B-$224.00M-$136.00M
Financing cash flow-$1.57B$1.63B-$2.82B-$2.03B-$961.00M$1.18B-$2.85B$1.30B
Depreciation & amortization$197.00M$195.00M-$246.00M$188.00M$188.00M$157.00M-$213.00M$153.00M
Dividends paid$96.00M$102.00M$101.00M$101.00M$89.00M$90.00M$91.00M$92.00M
Share buybacks$894.00M$2.53B$2.67B$680.00M$818.00M$581.00M$300.00M$827.00M

Free plan shows the latest 8 periods; Pro shows all 74 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.